Be a PRO & get up to 50% off on select brands. Explore Now
you are here: HomeNewsWorld

EU ready to 'discuss' COVID-19 vaccine patent waivers

European Commission President Ursula von der Leyen stressed that Europe's priority would be to boost global supplies, and implicitly criticised the US and the UK for limiting COVID-19 vaccine exports.

May 06, 2021 / 01:37 PM IST
Covid-19 vaccine (Representational image)

Covid-19 vaccine (Representational image)

European Commission President Ursula von der Leyen said Thursday that Brussels was ready discuss a US-backed proposal to waive patents on Covid-19 vaccines.

But she stressed that Europe's priority would be to boost global supplies, and implicitly criticised the US and the UK for limiting vaccine exports.

"The European Union is also ready to discuss any proposal that addresses the crisis in an effective and pragmatic manner," she told an online conference.

"And that's why we are ready to discuss how the US proposal for waiver on intellectual property protection for covered vaccines could help achieve that objective."

On Wednesday, US Trade Representative Katherine Tai said Washington now supports calls for a global waiver on patent protections for Covid-19 vaccines while the pandemic rages.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

US President Joe Biden had been under pressure to back the move, which could help poorer nations produce cheaper generic versions of the latest jabs.

The head of the World Health Organization, Tedros Adhanom Ghebreyesus, hailed Biden's "historic" decision, which Europe has up to now resisted.

Von der Leyen's commission has taken charge of procuring vaccines for the EU's 450 million inhabitants, and was criticised for a slow start.

But she told the online audience hosted by the European University institute, based in Florence, that the bloc is now getting up to speed.

"Some might say...countries like the US and the United Kingdom have been fast at the beginning. But I say Europe achieved this success while remaining open to the world, while others keep their vaccine production for themselves," she said.

"Europe is the main exporter of vaccines worldwide. So far, more than 200 million doses of vaccines produced in Europe have been shipped to the rest of the world," von der Leyen said.

"Europe exports as much vaccine as it delivers to its own citizens. And to be clear, Europe is the only democratic region in the world that exports vaccines on a large scale."
AFP
first published: May 6, 2021 01:37 pm

stay updated

Get Daily News on your Browser
Sections
Enjoying Moneycontrol?

How about a quick survey to help us improve our services?

Ok, sure

Maybe next time!